Drug intelligence / Profile preview

cyclacillin

Development stage
Unknown
Lead developer
Pfizer
Modality
Small Molecules
Administration
Oral
01

Overview

Cyclacillin is a semisynthetic aminopenicillin antibiotic and a cyclohexylamido analog of penicillanic acid. It was developed as an orally active penicillin with improved absorption and greater resistance to beta-lactamase hydrolysis compared to ampicillin. Its primary mechanism of action is the inhibition of bacterial cell wall synthesis through binding to penicillin-binding protein (PBP), resulting in bactericidal activity. Cyclacillin was used for the treatment of bacterial infections caused by susceptible organisms, including both gram-positive and some gram-negative bacteria. It has largely been replaced by newer penicillins due to advances in antibiotic therapy[1][2][3][4][5].

Brand names
CyclapenCyclapen-WVastcillin
Other names
ciclacillin
02

Targets

PBP (Penicillin-binding protein family)

Beyond the preview

Go deeper on cyclacillin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cyclacillin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call